BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23873335)

  • 21. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmodium berghei NK65 induces cerebral leukocyte recruitment in vivo: an intravital microscopic study.
    Lacerda-Queiroz N; Lima OC; Carneiro CM; Vilela MC; Teixeira AL; Teixeira-Carvalho A; Araújo MS; Martins-Filho OA; Braga EM; Carvalho-Tavares J
    Acta Trop; 2011; 120(1-2):31-9. PubMed ID: 21722620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.
    Choi SW; Hildebrandt GC; Olkiewicz KM; Hanauer DA; Chaudhary MN; Silva IA; Rogers CE; Deurloo DT; Fisher JM; Liu C; Adams D; Chensue SW; Cooke KR
    Blood; 2007 Nov; 110(9):3447-55. PubMed ID: 17641205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.
    Clouthier SG; Cooke KR; Teshima T; Lowler KP; Liu C; Connolly K; Ferrara JL
    Biol Blood Marrow Transplant; 2003 Sep; 9(9):592-603. PubMed ID: 14506661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.
    Maeda Y; Reddy P; Lowler KP; Liu C; Bishop DK; Ferrara JL
    Blood; 2005 Jul; 106(2):749-55. PubMed ID: 15797996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.
    Liang Y; Liu C; Djeu JY; Zhong B; Peters T; Scharffetter-Kochanek K; Anasetti C; Yu XZ
    Blood; 2008 Jan; 111(2):954-62. PubMed ID: 17928532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
    Nestel FP; Price KS; Seemayer TA; Lapp WS
    J Exp Med; 1992 Feb; 175(2):405-13. PubMed ID: 1732411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
    J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo.
    Kerfoot SM; Andonegui G; Bonder CS; Liu L
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2524-34. PubMed ID: 18424631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
    Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
    Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.
    Rotolo JA; Stancevic B; Lu SX; Zhang J; Suh D; King CG; Kappel LW; Murphy GF; Liu C; Fuks Z; van den Brink MR; Kolesnick R
    Blood; 2009 Oct; 114(17):3693-706. PubMed ID: 19666872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Butyric acid derivative induces allospecific T cell anergy and prevents graft-versus-host disease.
    Gilbert KM; Boger S; Fifer EK
    Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):13-27. PubMed ID: 12675196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.
    Martinu T; Gowdy KM; Nugent JL; Sun J; Kinnier CV; Nelson ME; Lyes MA; Kelly FL; Foster WM; Gunn MD; Palmer SM
    Am J Respir Cell Mol Biol; 2014 Dec; 51(6):810-21. PubMed ID: 24921973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chemerin/CMKLR1 axis regulates intestinal graft-versus-host disease.
    Dander E; Vinci P; Vetrano S; Recordati C; Piazza R; Fazio G; Bardelli D; Bugatti M; Sozio F; Piontini A; Bonanomi S; Bertola L; Tassistro E; Valsecchi MG; Calza S; Vermi W; Biondi A; Del Prete A; Sozzani S; D'Amico G
    JCI Insight; 2023 Mar; 8(5):. PubMed ID: 36883565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice.
    Ellison CA; Natuik SA; McIntosh AR; Scully SA; Danilenko DM; Gartner JG
    Immunology; 2003 Jul; 109(3):440-9. PubMed ID: 12807491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.
    Lim JY; Ryu DB; Lee SE; Park G; Choi EY; Min CK
    Mol Cells; 2015 Nov; 38(11):966-74. PubMed ID: 26552489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.